We welcome submissions from clinical diagnostics, molecular pathology, epidemiology, microbiology, genetics, and translational medicine. Studies should demonstrate clear relevance to identifying disease drivers, validating diagnostic approaches, or translating etiological insights into patient care. Multidisciplinary research connecting laboratory evidence with clinical outcomes is strongly encouraged.

Manuscripts should highlight the diagnostic problem addressed, the methodology used to establish etiology, and the impact on clinical practice, surveillance, or public health. We prioritize studies that improve diagnostic precision, reduce time to diagnosis, or enhance treatment selection through etiological clarity.

Our editorial team brings expertise in laboratory diagnostics, clinical microbiology, and disease causation research. We provide constructive peer review and transparent decision making to help authors strengthen study design, reporting clarity, and translational relevance. Accepted work is published with rich metadata and preserved for long term discoverability.

Include detailed methods, validated diagnostic criteria, and data availability statements. For multi site studies, explain harmonization and quality control. We encourage pre submission questions if you need guidance on fit or scope.

High impact submissions define the diagnostic question, describe the causal pathway investigated, and provide evidence that links findings to clinical or public health relevance. Studies should include robust validation, appropriate controls, and transparent data reporting.

We encourage authors to highlight how their work improves diagnostic accuracy, reduces time to diagnosis, or changes clinical decision making. Well structured methods and clear data availability statements help editors and reviewers assess reliability quickly.

All manuscripts must include ethics approvals and consent procedures where applicable. Disclose funding sources and conflicts of interest. Diagnostic studies involving human samples should explain handling protocols and data privacy safeguards.

Data availability and reproducibility statements are required. If data cannot be shared due to privacy restrictions, provide a clear rationale and a pathway for qualified access.

Short communications describing time sensitive etiological findings, outbreak related diagnostics, or early validation of novel tests are welcomed when supported by robust evidence. Clearly state the clinical or public health urgency in the abstract to help editors prioritize review.

Authors may also submit to active special issues when their topic aligns with a themed collection. These issues provide concentrated visibility and attract readership from researchers focused on specific etiological challenges.

Before submission, confirm that methods are reproducible, data availability statements are included, and any potential conflicts of interest are disclosed. Strong transparency accelerates review and improves acceptance decisions.

Confirm that your manuscript includes a clear diagnostic question, validated methods, and a data availability statement. Figures should be labeled with units and diagnostic thresholds, and references should include DOIs where possible.

A concise cover letter that explains novelty, clinical relevance, and etiological contribution helps editors select the right reviewers quickly.